Zions Bancorporation’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Zions Bancorporation’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.32M	Buy	107,141 +2,815	+3%	+$32.2K	0.08%	196
2024 Q3	$1.19M	Buy	104,326 +20,098	+24%	+$202K	0.09%	184
2024 Q2	$601K	Sell	84,228 -2,314	-3%	-$17.7K	0.05%	224
2024 Q1	$580K	Buy	86,542 +20,192	+30%	+$139K	0.04%	244
2023 Q4	$431K	Buy	66,350 +1,483	+2%	+$9.56K	0.03%	259
2023 Q3	$612K	Buy	+64,867	New	+$781K	0.05%	230
2023 Q1	–	Sell	-381	Closed	-$5.25K	–	1057
2022 Q4	$5.25K	Buy	+381	New	+$5.84K	﹤0.01%	844

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Zions Bancorporation's CDMO Position: Q4 2024 in Review

Zions Bancorporation increased its Avid Bioservices, Inc. Common Stock (CDMO) stake by 2.7% in Q4 2024, buying an estimated $32.2K and bringing the position to 107,141 shares worth $1.32M. The position accounts for 0.08% of the portfolio, ranked #196.

Zions Bancorporation first reported a position in CDMO in Q4 2022 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Zions Bancorporation held 107,141 shares of Avid Bioservices, Inc. Common Stock worth $1.32M as of Q4 2024.
Zions Bancorporation bought 2,815 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $32.2K.
Avid Bioservices, Inc. Common Stock made up 0.08% of Zions Bancorporation's portfolio in Q4 2024, its #196 holding.
Zions Bancorporation first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2022 and has held it in 7 quarters since.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.